Clinical Trials Browser

Enrolling by invitation × Interventional × Hodgkin Disease × Clear all

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Phase 2 Enrolling by invitation

Hodgkin Disease, Recurrence